The massive pharmaceuticals distributor said it is offering employees severance. It plans to begin layoffs on March 3.

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” third-quarter 2024 ...

Conventum – Alluvium Global Fund highlighted stocks like McKesson Corporation (NYSE:MCK), in the third quarter 2024 investor letter. McKesson Corporation (NYSE:MCK) offers healthcare services ...

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. We recently published an article titled Jim ...

Harrow's relaunch of Triesence, a preservative-free corticosteroid, is revolutionizing ophthalmology with safer and more ...

Mizuho assumed coverage of McKesson (MCK) with a Neutral rating and $630 price target The stock’s investment story has morphed well beyond just a plain vanilla drug distribution story ...

Valued at a market cap of $76.6 billion, Irving, Texas-based McKesson Corporation (MCK) is a leading healthcare services and information technology company. It operates globally through four ...

Jefferies analyst Brian Tanquilut maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $715.00. The company’s shares closed yesterday at $615.65.

This advertisement has not loaded yet, but your article continues below.